Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
September 30, 2025 -43.86M
June 30, 2025 -36.88M
March 31, 2025 -31.89M
December 31, 2024 -22.93M
September 30, 2024 -18.33M
June 30, 2024 1.430M
March 31, 2024 4.597M
December 31, 2023 7.403M
September 30, 2023 1.435M
June 30, 2023 -17.72M
March 31, 2023 -89.20M
December 31, 2022 -113.61M
September 30, 2022 -114.50M
Date Value
June 30, 2022 -80.71M
March 31, 2022 -24.86M
December 31, 2021 -0.5214M
September 30, 2021 -17.95M
June 30, 2021 -41.29M
March 31, 2021 -43.35M
December 31, 2020 -50.30M
September 30, 2020 -41.29M
June 30, 2020 -45.73M
March 31, 2020 -69.70M
December 31, 2019 -59.48M
September 30, 2019 -52.57M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
cbdMD, Inc. -2.218M
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. 189.47M
Corcept Therapeutics, Inc. 109.70M